PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me

Wegovy and Ozempic alternatives: every cheaper route, ranked by what it costs

The cheapest alternative to Wegovy or Ozempic is compounded semaglutide: semaglutide as the active ingredient, made by licensed pharmacies and sold through telehealth programs for a fraction of Novo Nordisk's price, and not FDA-approved. For an approved drug, the routes are Wegovy itself through NovoCare, the Wegovy and Ozempic pills, Lilly's Zepbound and Foundayo, and Mounjaro for type 2 diabetes. This guide prices each one from the maker's published terms and today's board.

11 min read · published October 2026, updated October 2026

Studio still life: an unlabelled glass vial beside a short stack of three plain coins

Key takeaways

  • 1Cheapest overall: compounded semaglutide, Wegovy's own molecule, priced live below from every partner program we track. It is not FDA-approved.
  • 2Cheapest way to stay on Wegovy itself: NovoCare Pharmacy, $199 for each of the first two months for new self-pay patients, then $349 a month up to 2.4 mg.
  • 3No needles: the Wegovy pill from NovoCare, $149 a month at 1.5 mg, and Lilly's Foundayo from $149 a month at its lowest dose.
  • 4A stronger molecule: tirzepatide (Zepbound) lost more weight than semaglutide in the head-to-head trial, 20.2% against 13.7%. Lilly sells Zepbound self-pay, and tirzepatide is also sold compounded.
  • 5On Ozempic for type 2 diabetes: the Ozempic pill (NovoCare self-pay from $149 a month) or Mounjaro, which lowered A1C more than Ozempic's 1 mg dose in SURPASS-2.

The cheapest alternative to Wegovy is Wegovy's own molecule, semaglutide, compounded by a licensed pharmacy and sold through a telehealth program. It costs a fraction of Novo Nordisk's price and it is not FDA-approved. Everything else on this page is an approved drug, and each one is cheaper than a pharmacy-priced Wegovy pen in a different way: a cheaper way to buy Wegovy itself, a pill, a different molecule, or a diabetes label your insurance may already pay for. Here is the floor today, read from every partner program we track:

Below, each alternative in the order most people look at them, with what it costs to stay on it, not just the first month.

Semaglutide, compounded

Compounded semaglutide is the alternative most people who search this end up choosing, because it uses semaglutide as its active ingredient at a much lower monthly price. The trade is the approval. In FDA's words: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed."1 The pharmacy's state licence, not an FDA review of the finished product, is what stands behind the vial.

Every price below is read from the seller's own page, ranked cheapest first, with any membership fee counted in:

Before you pick one, read how compounded semaglutide compares with Wegovy and check the seller in ten minutes. A price gap this large attracts bad actors as well as good pharmacies.

First, the cheaper Wegovy

If the problem is the pharmacy price, the next alternative is Wegovy bought another way. Novo Nordisk sells it directly to people paying cash through NovoCare Pharmacy. New self-pay patients pay $199 for each of the first two months at 0.25 mg and 0.5 mg, then $349 a month for every pen dose up to 2.4 mg, and $399 for the 7.2 mg high dose.2 The two-month starter offer runs "through December 31, 2026", in Novo's words.

That is still $349 a month at the doses that do the work. The Wegovy cost guide prices the whole first year.

No needles: the Wegovy pill and Foundayo

Two weight-loss pills are now approved, and both are priced below the Wegovy pen at their starting doses.

The Wegovy pill is oral semaglutide, the same molecule as the pen. In Novo Nordisk's own words, "Wegovy is the first FDA-approved semaglutide pill for weight loss."3 NovoCare sells it to self-pay patients at $149 for each month of 1.5 mg, $199 for 4 mg and $299 for 9 mg and 25 mg.2 At every dose that is less than the $349 pen.

Foundayo is orforglipron, Lilly's pill. Lilly says "Individuals opting for self-pay can access Foundayo starting at $149 per month for the lowest dose." In the ATTAIN-1 trial, people on the highest dose who stayed on treatment lost 12.4% of their body weight, against 0.9% on placebo.7 That is a smaller average loss than the injections, in a different trial, so treat the comparison as rough.

Programs on our board that sell an oral GLP-1, cheapest first:

More in the Wegovy pill vs injection guide and the Foundayo vs Wegovy pill guide.

A stronger molecule: tirzepatide

Zepbound is Lilly's tirzepatide, approved for weight loss, and it is the approved alternative people compare Wegovy with most. The two drugs were tested against each other in SURMOUNT-5, a 72-week trial of 751 adults with obesity: tirzepatide reduced weight by 20.2% and semaglutide by 13.7%.4 If Wegovy is not working well enough, this is the alternative with the trial behind it.

Lilly sells Zepbound to people paying cash, priced by dose. Its self-pay ladder, from the manufacturer prices we track, is below; the Zepbound cost without insurance guide works through the first year.

Tirzepatide is also sold compounded, by many of the same programs. The same FDA caveat applies.1

The Zepbound vs Wegovy guide goes through the two side by side, and the switching guide quotes what the labels say about moving from one to the other.

Ozempic alternatives

Ozempic is semaglutide too, made by Novo Nordisk. Its label reads "OZEMPIC is indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus."8 So the answer to "what is an alternative to Ozempic" depends on why you take it.

If you want it for weight loss

Everything above this heading applies to you, because Wegovy is the weight-loss label of the same molecule. Plans that refuse Wegovy generally will not pay for Ozempic off label either, and whether to prescribe it is your clinician's call. Paying cash, Ozempic is not cheaper than Wegovy: NovoCare charges new self-pay patients $199 for each of the first two months, then $349 a month up to 1 mg and $499 for 2 mg.2 The Ozempic coupon guide explains why Novo's savings offer needs a labeled use.

If you take it for type 2 diabetes

Here the alternatives are the drugs on the same diabetes label, and coverage usually decides more than the cash price.

  • The Ozempic pill. Semaglutide as a daily tablet. The label covers the same use as the pen: "as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus."9 It is not a mg-for-mg swap with Rybelsus, the older semaglutide tablet: the label says the two "are not substitutable on a mg-to-mg basis".9 NovoCare Pharmacy sells it with "self-pay options starting at $149/month" for people who are uninsured or whose commercial plan does not cover it.10 A self-pay fill is processed outside your insurance and does not count toward a deductible.10 The Rybelsus guide covers the move from Rybelsus to the Ozempic pill.
  • Mounjaro. Lilly's tirzepatide on a diabetes label, indicated "to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus."5 SURPASS-2 put it against Ozempic's 1 mg dose for 40 weeks in 1,879 adults: A1C fell 2.01 to 2.30 points on the three tirzepatide doses against 1.86 on semaglutide, and weight fell 1.9 to 5.5 kg more on tirzepatide. Lilly funded the trial.6 The Mounjaro cost guide prices it.
  • Compounded semaglutide. The board above sells to anyone with a prescription, diabetes or not, with the same FDA caveat as before.1 If your plan already covers a diabetes drug, check your copay against the board before you switch to paying cash.
Ozempic alternativeMoleculeLabelFormPaying cash
Ozempic pillsemaglutideType 2 diabetesdaily tabletNovo's price: from $149 a month
MounjarotirzepatideType 2 diabetesweekly injectionLilly's price, in the Mounjaro cost guide
WegovysemaglutideWeight lossweekly injection or daily tabletNovo's prices above
ZepboundtirzepatideWeight lossweekly injectionLilly's ladder above
Compounded semaglutidesemaglutideNone, not FDA-approvedweekly injectionlive on the board above

Changing from one diabetes medicine to another is your prescriber's decision, including the starting dose; none of these is a straight swap.

All six side by side

AlternativeMoleculeFDA-approved for weight lossFormWhat it costs
Compounded semaglutidesemaglutideNo, not FDA-approvedweekly injectionlive on the board above
Wegovy, NovoCaresemaglutideYesweekly injectionNovo's prices: $199 for two months for new patients, then $349
Wegovy pillsemaglutideYesdaily tabletNovo's prices: $149 to $299 by dose
FoundayoorforglipronYesdaily tabletLilly's price: from $149 at the lowest dose
Zepbound, Lilly self-paytirzepatideYesweekly injectionLilly's self-pay ladder above, by dose
Compounded tirzepatidetirzepatideNo, not FDA-approvedweekly injectionlive on the board above

Ozempic and Mounjaro are left out of this table because neither is approved for weight loss; their alternatives are in the Ozempic section above.

Which one fits

  • You want the lowest monthly price and accept a compounded product: compounded semaglutide keeps you on the molecule you already know.
  • You want to stay on approved Wegovy for less: NovoCare self-pay, or the Wegovy pill, which costs less than the pen at every dose.
  • You want the best trial result: tirzepatide, as Zepbound from Lilly self-pay or compounded from the board.
  • You do not want injections: the Wegovy pill or Foundayo, both priced lowest at their starting doses.
  • You have type 2 diabetes: ask whether your plan covers Ozempic, the Ozempic pill or Mounjaro before paying cash for anything.

Switching between any of these is a prescribing decision with its own dose plan; follow your prescriber.

Sources10
  1. FDA, Compounding and the FDA: Questions and Answers read October 2026“Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.” ↩
  2. NovoCare Pharmacy, Wegovy and Ozempic self-pay prices (pill and pen) read October 2026“Patients pay $149 for each month of 1.5 mg, $199 per month for 4 mg and $299 per month for 9 mg and 25 mg. ... Patients new to the Wegovy® Savings Offer and NovoCare® Pharmacy pay $199 for each month of 0.25 mg and 0.5 mg. Offer is for 2 monthly fills through December 31, 2026, then $349 per month for Wegovy® 0.25 mg, 0.5 mg, 1 mg, 1.7 mg or 2.4 mg and $399 per month for Wegovy® HD (semaglutide) injection 7.2 mg. ... Patients new to the Ozempic® Savings Offer and NovoCare® Pharmacy pay $199 for each month of 0.25 mg and 0.5 mg. Offer for 2 monthly fills through December 31, 2026 then $349 per month for Ozempic® 0.25 mg, 0.5 mg or 1 mg and $499 per month for Ozempic® 2 mg.” ↩
  3. Wegovy.com, the tablet read October 2026“Wegovy is the first FDA-approved semaglutide pill for weight loss.” ↩
  4. Aronne et al., Tirzepatide as Compared with Semaglutide for the Treatment of Obesity, N Engl J Med 2025 (SURMOUNT-5) read October 2026“A total of 751 participants underwent randomization. The least-squares mean percent change in weight at week 72 was -20.2% (95% confidence interval [CI], -21.4 to -19.1) with tirzepatide and -13.7% (95% CI, -14.9 to -12.6) with semaglutide (P<0.001).” ↩
  5. Mounjaro prescribing information (DailyMed), indications read October 2026“as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.” ↩
  6. Frías et al., Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes, N Engl J Med 2021 (SURPASS-2, funded by Eli Lilly) read October 2026“In an open-label, 40-week, phase 3 trial, we randomly assigned 1879 patients, in a 1:1:1:1 ratio, to receive tirzepatide at a dose of 5 mg, 10 mg, or 15 mg or semaglutide at a dose of 1 mg. ... The estimated mean change from baseline in the glycated hemoglobin level was -2.01 percentage points, -2.24 percentage points, and -2.30 percentage points with 5 mg, 10 mg, and 15 mg of tirzepatide, respectively, and -1.86 percentage points with semaglutide ... Reductions in body weight were greater with tirzepatide than with semaglutide (least-squares mean estimated treatment difference, -1.9 kg, -3.6 kg, and -5.5 kg, respectively; P<0.001 for all comparisons).” ↩
  7. Eli Lilly, Foundayo FDA approval announcement (self-pay price and ATTAIN-1 result) read October 2026“In the ATTAIN-1 trial, individuals taking the highest dose of Foundayo and who stayed on treatment lost an average of 27.3 pounds (12.4%) compared to 2.2 pounds (0.9%) with placebo. ... Individuals opting for self-pay can access Foundayo starting at $149 per month for the lowest dose.” ↩
  8. Ozempic prescribing information (DailyMed), indications read October 2026“OZEMPIC is indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.” ↩
  9. Rybelsus and Ozempic tablets prescribing information (DailyMed), sections 1 and 2.1 read October 2026“RYBELSUS and OZEMPIC tablets are indicated ... as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ... RYBELSUS and OZEMPIC tablets are not substitutable on a mg-to-mg basis.” ↩
  10. NovoCare Pharmacy, Ozempic pill self-pay terms (Novo Nordisk) read October 2026“There are self-pay options starting at $149/month if your commercial insurance doesn’t cover your medication, or if you are uninsured. ... If you choose the self-pay option, it means your prescription will be processed outside of your insurance, will not count toward any deductibles, and cannot be applied to any insurance maximum out-of-pocket limits.” ↩

Common questions

What is the cheapest alternative to Wegovy?

Compounded semaglutide, which uses the active ingredient in Wegovy, is not FDA-approved, and is made by a licensed compounding pharmacy and sold through telehealth programs. Our board ranks every partner program's current price, read from the seller's own page. It is not FDA-approved: FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.

Is there a cheaper FDA-approved alternative to Wegovy?

Yes. The Wegovy pill is $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg through NovoCare Pharmacy, less than the pen at every dose. Lilly's Foundayo pill starts at $149 a month at its lowest dose. The Wegovy pen itself is $199 a month for the first two fills for new NovoCare self-pay patients, then $349 a month up to 2.4 mg.

Is anything more effective than Wegovy?

In the head-to-head trial, tirzepatide was. In SURMOUNT-5, a 72-week trial of 751 adults with obesity, tirzepatide (Zepbound's molecule) reduced body weight by 20.2% and semaglutide (Wegovy's molecule) by 13.7%. Lilly sells Zepbound self-pay, priced by dose; its ladder is on this page.

Is Ozempic an alternative to Wegovy?

It is the same drug, semaglutide, from the same maker, but its label is for type 2 diabetes, not weight loss. For someone with type 2 diabetes whose plan covers Ozempic it can be the cheapest route to semaglutide. Paying cash it is not cheaper: NovoCare charges $349 a month up to 1 mg after the two-month starter offer, and $499 for 2 mg.

Is there a pill alternative to Wegovy?

Two. The Wegovy pill is oral semaglutide, $149 to $299 a month by dose through NovoCare Pharmacy. Foundayo is Lilly's orforglipron pill, from $149 a month at the lowest dose on self-pay. In Lilly's ATTAIN-1 trial, people on the highest Foundayo dose who stayed on treatment lost 12.4% of their body weight on average.

What are the alternatives to Ozempic?

For weight loss: Wegovy, which is the same semaglutide on a weight-loss label, the Wegovy pill, Zepbound, Foundayo, or compounded semaglutide, which is not FDA-approved. For type 2 diabetes: the Ozempic pill, which NovoCare sells self-pay from $149 a month, or Mounjaro, Lilly's tirzepatide on the diabetes label. Your prescriber decides any switch.

Is Mounjaro better than Ozempic for type 2 diabetes?

In SURPASS-2, a 40-week trial of 1,879 adults with type 2 diabetes funded by Lilly, all three tirzepatide doses lowered A1C more than Ozempic's 1 mg dose: 2.01 to 2.30 points against 1.86. Weight also fell 1.9 to 5.5 kg more on tirzepatide. The trial compared semaglutide 1 mg, not Ozempic's 2 mg dose.

Is the Ozempic pill cheaper than the Ozempic pen?

Paying cash at NovoCare Pharmacy, the Ozempic pill has self-pay options starting at $149 a month. The pen is $199 a month for the first two fills for new self-pay patients, then $349 a month up to 1 mg and $499 for 2 mg. With insurance, your plan sets the cost of either.

Choosing a program? See our ranking of the best online GLP-1 programs for every partner side by side, or the cheapest semaglutide page for price alone.

Next steps

Read next

GLP-1 TV

Watch: videos on this

From GLP-1 TV, the videos closest to this page by what is said in them, with our summary of each.

Every GLP-1 video

More free tools

Every free tool · Every guide